Nuance Announces series B fundraising led by C-Bridge Capital to commercialize high-value pharmaceuticals in China

SHANGHAI, China, June 27, 2018 (GLOBE NEWSWIRE) — Nuance Biotech, a China-based specialty pharmaceutical company, today announced Series B fundraising of US$20 million with additional capital US$15 million tied to its acquisition of new products …
( read original story …)